West Paces Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.07K | Buy |
+52
| New | +$4.2K | ﹤0.01% | 482 |
|
|
2025
Q2 | – | Sell |
-10
| Closed | -$899 | – | 415 |
|
|
2025
Q1 | $899 | Hold |
10
| – | – | ﹤0.01% | 499 |
|
|
2024
Q4 | $799 | Hold |
10
| – | – | ﹤0.01% | 501 |
|
|
2024
Q3 | $900 | Hold |
10
| – | – | ﹤0.01% | 480 |
|
|
2024
Q2 | $787 | Hold |
10
| – | – | ﹤0.01% | 508 |
|
|
2024
Q1 | $872 | Sell |
10
-519
| -98% | -$44.3K | ﹤0.01% | 513 |
|
|
2023
Q4 | $43.6K | Sell |
529
-3,959
| -88% | -$302K | 0.01% | 238 |
|
|
2023
Q3 | $352K | Sell |
4,488
-1,086
| -19% | -$90.9K | 0.11% | 92 |
|
|
2023
Q2 | $491K | Sell |
5,574
-1,136
| -17% | -$97.8K | 0.14% | 78 |
|
|
2023
Q1 | $541K | Sell |
6,710
-466
| -6% | -$38K | 0.17% | 76 |
|
|
2022
Q4 | $558K | Buy |
7,176
+89
| +1% | +$7.21K | 0.18% | 77 |
|
|
2022
Q3 | $572K | Buy |
7,087
+61
| +0.9% | +$5.48K | 0.2% | 72 |
|
|
2022
Q2 | $631K | Sell |
7,026
-3
| -0% | -$304 | 0.21% | 68 |
|
|
2022
Q1 | $780K | Buy |
7,029
+403
| +6% | +$42.6K | 0.24% | 65 |
|
|
2021
Q4 | $685K | Sell |
6,626
-64
| -1% | -$7.41K | 0.21% | 68 |
|
|
2021
Q3 | $839K | Buy |
6,690
+57
| +0.9% | +$7.38K | 0.29% | 56 |
|
|
2021
Q2 | $823K | Sell |
6,633
-323
| -5% | -$40.6K | 0.3% | 55 |
|
|
2021
Q1 | $822K | Buy |
6,956
+107
| +2% | +$12.5K | 0.33% | 57 |
|
|
2020
Q4 | $802K | Buy |
6,849
+23
| +0.3% | +$2.53K | 0.36% | 56 |
|
|
2020
Q3 | $709K | Buy |
6,826
+260
| +4% | +$26.1K | 0.36% | 58 |
|
|
2020
Q2 | $602K | Sell |
6,566
-64
| -1% | -$6.14K | 0.33% | 63 |
|
|
2020
Q1 | $598K | Sell |
6,630
-798
| -11% | -$84.9K | 0.38% | 52 |
|
|
2019
Q4 | $843K | Sell |
7,428
-171
| -2% | -$18.8K | 0.46% | 47 |
|
|
2019
Q3 | $825K | Hold |
7,599
| – | – | 0.49% | 46 |
|
|
2019
Q2 | $740K | Sell |
7,599
-234
| -3% | -$21.4K | 0.46% | 46 |
|
|
2019
Q1 | $713K | Buy |
7,833
+137
| +2% | +$12.3K | 0.5% | 44 |
|
|
2018
Q4 | $700K | Sell |
7,696
-52
| -0.7% | -$4.86K | 0.54% | 48 |
|
|
2018
Q3 | $762K | Sell |
7,748
-83
| -1% | -$7.67K | 0.55% | 43 |
|
|
2018
Q2 | $670K | Buy |
7,831
+60
| +0.8% | +$5.01K | 0.5% | 51 |
|
|
2018
Q1 | $623K | Buy |
7,771
+1,055
| +16% | +$87K | 0.46% | 50 |
|
|
2017
Q4 | $542K | Sell |
6,716
-112
| -2% | -$8.97K | 0.4% | 63 |
|
|
2017
Q3 | $531K | Sell |
6,828
-836
| -11% | -$69.4K | 0.4% | 56 |
|
|
2017
Q2 | $680K | Buy |
7,664
+1,705
| +29% | +$144K | 0.54% | 41 |
|
|
2017
Q1 | $480K | Buy |
5,959
+786
| +15% | +$61.4K | 0.38% | 62 |
|
|
2016
Q4 | $368K | Buy |
+5,173
| New | +$406K | 0.34% | 72 |
|
Other funds holding MDT
LMFP
FWIA
DC
CAI
ETC
GI
MAA
West Paces Advisors's MDT Position: Q2 2026 in Review
West Paces Advisors opened a new position in Medtronic (MDT) in Q2 2026: 52 shares worth $4.07K. The stake represents ﹤0.01% of the portfolio and ranks #482 among its holdings. This is a return to the name: West Paces Advisors previously reported a position in MDT as recently as Q1 2025.
West Paces Advisors first reported a position in MDT in Q4 2016 and has held it in 35 quarters since. The position peaked at $843K in Q4 2019. 546 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- West Paces Advisors held 52 shares of Medtronic worth $4.07K as of Q2 2026.
- Medtronic was a new West Paces Advisors position in Q2 2026.
- Medtronic made up ﹤0.01% of West Paces Advisors's portfolio in Q2 2026, its #482 holding.
- West Paces Advisors first reported a position in Medtronic in Q4 2016 and has held it in 35 quarters since.
- West Paces Advisors's Medtronic position peaked at $843K in Q4 2019.
- 546 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on West Paces Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.